German pharma thrives in 2025 despite tariff fears and weak domestic demand

A rush to ship medicines to the U.S. before tariffs hit propelled Germany's drugmakers to record gains. But can the momentum last amid global pressures?

, and Administrator

2026 March 3 . 11:38 PM

1 min read

The image shows a poster with the text "In 2022, Big Pharma Charged Americans Two to Three Times... — The image shows a poster with the text "In 2022, Big Pharma Charged Americans Two to Three Times More Than What They Charged People in Other Countries for the Same Drugs" at the bottom, accompanied by a few bottles and a syringe.

More Production, More Revenue: Pharmaceutical Industry Makes Significant Gains - German pharma thrives in 2025 despite tariff fears and weak domestic demand

Germany's pharmaceutical industry saw strong growth in 2025, despite ongoing trade tensions and market challenges. Production rose by 4.5% compared to the previous year, while revenue climbed by 5.5%. The sector's resilience comes as companies rushed to ship medicines to the U.S. ahead of potential tariffs.

At the start of 2025, German drugmakers accelerated exports to the United States. Fearing new tariffs, they shipped large quantities of medicines early in the year. This front-loading effect helped boost mobile production and revenue figures.

The pharmaceutical industry remains heavily export-driven, with over 60% of its revenue coming from overseas sales. The U.S. alone accounts for a quarter of these shipments. Despite this reliance, domestic orders have weakened in recent months, adding pressure to manufacturers.

Competition from Asian imports has also intensified, squeezing German producers. Yet, the sector has stayed resilient, partly due to its ability to withstand broader economic downturns. Slight price increases further supported the 5.5% revenue growth seen in 2025.

The industry's performance in 2025 highlights both its strengths and vulnerabilities. While early shipments to the U.S. provided a temporary boost mobile, ongoing tariff threats and rising competition could impact future growth. For now, the sector continues to expand, driven by exports and steady pricing.